| Financial Year |
March 31 2023 |
| Monetary Funds |
1,347,480,273.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,300,000.00 |
| Accounts Receivable |
492,279,806.67 |
| Advances to Suppliers |
126,589,082.15 |
| Other Receivables |
23,934,471.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,972,934,167.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
163,145,711.66 |
| Total Current Assets |
5,172,839,164.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
84,900,299.36 |
| Investment Properties |
169,969,434.38 |
| Fixed Assetes |
159,198,239.50 |
| Under-construction Projects |
559,960,316.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,442,099.48 |
| R&D expenses |
-- |
| Goodwill |
7,260,749.12 |
| Long-Term Deferred and Prepaid Expenses |
170,865.30 |
| Deferred Income Tax Assets |
358,880,722.57 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,359,315,238.39 |
| Total Assets |
6,532,154,402.65 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
182,588,775.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,078,827.71 |
| Taxes Payable |
87,752,017.65 |
| Interest Payable |
-- |
| Dividend Payable |
1,500,000.00 |
| Other payables |
1,144,597,109.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,831,239.95 |
| Other Current Liabilities |
30,771,985.37 |
| Sub-Total of Current Liabilities |
1,828,345,790.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,688,162.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,045,376.13 |
| Total Liabilities |
1,839,391,166.95 |
| Paid-In Capital(Or Share Stock) |
809,095,632.00 |
| Capital Surplus |
135,159,358.28 |
| Surplus Reserve |
407,500,380.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,293,122,202.38 |
| Minority Stockholder's Interest |
47,885,662.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,644,877,573.51 |
| Owner's Equity（Stockholder's Equity） |
4,692,763,235.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,532,154,402.65 |
